Arginase Plays a Pivotal Role in Polyamine Precursor Metabolism in Leishmania

The polyamine pathway of protozoan parasites has been successfully targeted in anti-parasitic therapies and is significantly different from that of the mammalian host. To gain knowledge into the metabolic routes by which parasites synthesize polyamines and their precursors, the arginase gene was cloned from Leishmania mexicana, and Δarg null mutants were created by double targeted gene replacement and characterized. The ARG sequence exhibited significant homology to ARG proteins from other organisms and predicted a peroxisomal targeting signal (PTS-1) that steers proteins to the glycosome, an organelle unique to Leishmania and related parasites. ARG was subsequently demonstrated to be present in the glycosome, whereas the polyamine biosynthetic enzymes, in contrast, were shown to be cytosolic. The Δarg knockouts expressed no ARG activity, lacked an intracellular ornithine pool, and were auxotrophic for ornithine or polyamines. The ability of the Δarg null mutants to proliferate could be restored by pharmacological supplementation, either with low putrescine or high ornithine or spermidine concentrations, or by complementation with an arginase episome. Transfection of an arg construct lacking the PTS-1 directed the synthesis of an arg that mislocalized to the cytosol and notably also complemented the genetic lesion and restored polyamine prototrophy to the Δarg parasites. This molecular, biochemical, and genetic dissection of ARG function in L. mexicana promastigotes establishes: (i) that the enzyme is essential for parasite viability; (ii) that Leishmania, unlike mammalian cells, expresses only one ARG activity; (iii) that the sole vital function of ARG is to provide polyamine precursors for the parasite; and (iv) that ARG is present in the glycosome, but this subcellular milieu is not essential for its role in polyamine biosynthesis.

[1]  J. Walker Creatine: biosynthesis, regulation, and function. , 2006, Advances in enzymology and related areas of molecular biology.

[2]  B. Ullman,et al.  Polyamine biosynthetic enzymes as drug targets in parasitic protozoa. , 2003, Biochemical Society transactions.

[3]  Michael P. Barrett,et al.  Genetic characterization of glucose transporter function in Leishmania mexicana , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  N. Yarlett,et al.  Polyamine metabolism as chemotherapeutic target in protozoan parasites. , 2002, Mini reviews in medicinal chemistry.

[5]  W. Liu,et al.  Peroxisomal targeting protein 14 (PEX14) from Leishmania donovani. Molecular, biochemical, and immunocytochemical characterization. , 2002, Molecular and biochemical parasitology.

[6]  L. Floeter-Winter,et al.  Genomic organisation and transcription characterisation of the gene encoding Leishmania (Leishmania) amazonensis arginase and its protein structure prediction. , 2002, International journal for parasitology.

[7]  W. Grody,et al.  Cloning and characterization of human agmatinase. , 2002, Molecular genetics and metabolism.

[8]  N. Carter,et al.  S-adenosylmethionine decarboxylase from Leishmania donovani. Molecular, genetic, and biochemical characterization of null mutants and overproducers. , 2002, The Journal of biological chemistry.

[9]  N. Carter,et al.  Genetic analysis of spermidine synthase from Leishmania donovani. , 2001, Molecular and biochemical parasitology.

[10]  T Furuya,et al.  Biogenesis and function of peroxisomes and glycosomes. , 2001, Molecular and biochemical parasitology.

[11]  S. Müller,et al.  Targeting polyamines of parasitic protozoa in chemotherapy. , 2001, Trends in parasitology.

[12]  V. Iniesta,et al.  The Inhibition of Arginase by N ω-Hydroxy-l-Arginine Controls the Growth of Leishmania Inside Macrophages , 2001, The Journal of experimental medicine.

[13]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[14]  J L Risler,et al.  Phylogeny of related functions: the case of polyamine biosynthetic enzymes. , 2000, Microbiology.

[15]  I. D. Algranati,et al.  Trypanosoma cruzi epimastigotes lack ornithine decarboxylase but can express a foreign gene encoding this enzyme , 1999, FEBS letters.

[16]  A. Fairlamb,et al.  Ornithine Decarboxylase Gene Deletion Mutants of Leishmania donovani * , 1999, The Journal of Biological Chemistry.

[17]  W Degrave,et al.  Genetic nomenclature for Trypanosoma and Leishmania. , 1998, Molecular and biochemical parasitology.

[18]  Guoyao Wu,et al.  Arginine metabolism: nitric oxide and beyond. , 1998, The Biochemical journal.

[19]  H. Hwang,et al.  Localization and Targeting of the Leishmania donovaniHypoxanthine-Guanine Phosphoribosyltransferase to the Glycosome* , 1998, The Journal of Biological Chemistry.

[20]  J. Perozich,et al.  Roles of conserved residues in the arginase family. , 1998, Biochimica et biophysica acta.

[21]  D. Christianson,et al.  Structure of a unique binuclear manganese cluster in arginase , 1996, Nature.

[22]  S. Beverley,et al.  Use of the green fluorescent protein as a marker in transfected Leishmania. , 1996, Molecular and biochemical parasitology.

[23]  R. Madhubala,et al.  Leishmania donovani: cellular control of ornithine decarboxylase in promastigotes. , 1995, The international journal of biochemistry & cell biology.

[24]  J. Blattner,et al.  Function of N‐terminal import signals in trypanosome microbodies , 1995, FEBS letters.

[25]  N. Grishin,et al.  Formation of functional cross-species heterodimers of ornithine decarboxylase. , 1994, Biochemistry.

[26]  J. Sommer,et al.  Phosphoenolpyruvate carboxykinase of Trypanosoma brucei is targeted to the glycosomes by a C‐terminal sequence , 1994, FEBS letters.

[27]  S. Beverley,et al.  Two more independent selectable markers for stable transfection of Leishmania. , 1993, Molecular and biochemical parasitology.

[28]  N. Yarlett,et al.  Effects of antagonists of polyamine metabolism on African trypanosomes. , 1993, Acta tropica.

[29]  A. Bitonti,et al.  Cure of murine Trypanosoma brucei rhodesiense infections with an S-adenosylmethionine decarboxylase inhibitor , 1992, Antimicrobial Agents and Chemotherapy.

[30]  F. Opperdoes,et al.  A chemostat study on proline uptake and metabolism of Leishmania donovani. , 1992, The Journal of protozoology.

[31]  B. Ullman,et al.  Amplification and molecular cloning of the ornithine decarboxylase gene of Leishmania donovani. , 1992, The Journal of biological chemistry.

[32]  E. Shapira Techniques in diagnostic human biochemical genetics , 1991 .

[33]  S. Beverley,et al.  Double targeted gene replacement for creating null mutants. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Beverley,et al.  Stable DNA transfection of a wide range of trypanosomatids. , 1991, Molecular and biochemical parasitology.

[35]  C. Clayton,et al.  Recognition of a peroxisomal tripeptide entry signal by the glycosomes of Trypanosoma brucei. , 1991, Molecular and biochemical parasitology.

[36]  S. Beverley,et al.  Development of a stable Leishmania expression vector and application to the study of parasite surface antigen genes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Beverley,et al.  Gene replacement in parasitic protozoa , 1990, Nature.

[38]  A. Bitonti,et al.  Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase , 1990, Antimicrobial Agents and Chemotherapy.

[39]  M. Phillips,et al.  Trypanosome ornithine decarboxylase is stable because it lacks sequences found in the carboxyl terminus of the mouse enzyme which target the latter for intracellular degradation. , 1990, The Journal of biological chemistry.

[40]  A. Bitonti,et al.  Alpha-difluoromethylornithine resistance in Leishmania donovani is associated with increased ornithine decarboxylase activity. , 1990, Molecular and biochemical parasitology.

[41]  S Subramani,et al.  A conserved tripeptide sorts proteins to peroxisomes , 1989, The Journal of cell biology.

[42]  L. Ghoda,et al.  Prevention of rapid intracellular degradation of ODC by a carboxyl-terminal truncation. , 1989, Science.

[43]  A. Fairlamb,et al.  Novel biochemical pathways in parasitic protozoa , 1989, Parasitology.

[44]  A. Bitonti,et al.  Plasmodium falciparum and Plasmodium berghei: effects of ornithine decarboxylase inhibitors on erythrocytic schizogony. , 1987, Experimental parasitology.

[45]  M. Phillips,et al.  Cloning and sequencing of the ornithine decarboxylase gene from Trypanosoma brucei. Implications for enzyme turnover and selective difluoromethylornithine inhibition. , 1987, The Journal of biological chemistry.

[46]  B. Aronow,et al.  Two high affinity nucleoside transporters in Leishmania donovani. , 1987, Molecular and biochemical parasitology.

[47]  P. McCann,et al.  Effects of DL-alpha-difluoromethylornithine on Leishmania donovani promastigotes. , 1986, The Journal of protozoology.

[48]  K. Chang,et al.  Heme requirement and acquisition by extracellular and intracellular stages of Leishmania mexicana amazonensis. , 1985, Molecular and biochemical parasitology.

[49]  D. Zilberstein,et al.  Protonmotive force-driven active transport of D-glucose and L-proline in the protozoan parasite Leishmania donovani. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[50]  F. Opperdoes,et al.  The occurrence of glycosomes (microbodies) in the promastigote stage of four major Leishmania species. , 1984, Molecular and biochemical parasitology.

[51]  D. Zilberstein,et al.  Glucose transport in Leishmania donovani promastigotes. , 1984, Molecular and biochemical parasitology.

[52]  D. S. Reiner,et al.  Inhibition of growth of Giardia lamblia by difluoromethylornithine, a specific inhibitor of polyamine biosynthesis. , 1984, The Journal of protozoology.

[53]  D. Iovannisci,et al.  High efficiency plating method for Leishmania promastigotes in semidefined or completely-defined medium. , 1983, The Journal of parasitology.

[54]  W. Gutteridge,et al.  UMP synthesis in the kinetoplastida. , 1982, Biochimica et biophysica acta.

[55]  P. McCann,et al.  Polyamine metabolism: a potential therapeutic target in trypanosomes. , 1980, Science.

[56]  E. Camargo,et al.  Trypanosoma spp., Leishmania spp. and Leptomonas spp.: enzymes of ornithine-arginine metabolism. , 1978, Experimental parasitology.

[57]  F. Opperdoes,et al.  Localization of nine glycolytic enzymes in a microbody‐like organelle in Trypanosoma brucei: The glycosome , 1977, FEBS letters.

[58]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[59]  S. Krassner,et al.  Essential amino acids in the culture of Leishmania tarentolae. , 1971, The Journal of parasitology.

[60]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[61]  R. Balaña-Fouce,et al.  Polyamine content and drug sensitivities of different clonal lines ofLeishmania infantum promastigotes , 2004, Parasitology Research.

[62]  D Steverding,et al.  A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue. , 2000, Parasitology international.

[63]  D. Agard,et al.  Fluorescence microscopy in three dimensions. , 1989, Methods in cell biology.

[64]  S. Müller,et al.  The polyamine metabolism of filarial worms as chemotherapeutic target. , 1988, Advances in experimental medicine and biology.

[65]  P. McCann,et al.  Inhibition of polyamine metabolism : biological significance and basis for new therapies , 1987 .

[66]  A. Sjoerdsma,et al.  16 – Clinical Aspects of Inhibition of Ornithine Decarboxylase with Emphasis on Therapeutic Trials of Eflornithine (DFMO) in Cancer and Protozoan Diseases , 1987 .

[67]  P. McCann,et al.  15 – Parasitic Protozoa and Polyamines , 1987 .